Physician profile
Mark Robert Miller
NPI 1881629327
$2,049.12
in general payments reported to CMS, 2019-2025
17 companies · $850 in 2025
The $850 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $35.61 · 2021: $197 · 2022: $160 · 2023: $54.57 · 2024: $595 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,499.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $520.49 | 2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Alcon Vision LLC | $290.65 | 2023-2025 | Clareon, Argos, Rocklatan |
| Novartis Pharmaceuticals Corporation | $274.07 | 2019-2022 | |
| Abbvie INC. | $220.23 | 2021-2025 | |
| Ani Pharmaceuticals, INC. | $142.30 | 2025 | Purified Cortrophin Gel |
| Genmab U.S., INC. | $120.06 | 2024 | Tivdak |
| Abbott Laboratories | $107.14 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $84.66 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $47.44 | 2019-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $45.64 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $39.79 | 2021-2022 | |
| Oyster Point Pharma, INC. | $37.68 | 2022-2024 | Ryzumvi, Tyrvaya |
| Allergan, INC. | $29.09 | 2021 | |
| Aerie Pharmaceuticals, INC. | $27.08 | 2021 | |
| Bausch & Lomb Americas INC. | $25.77 | 2024 | Miebo, Vyzulta |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $19.00 | 2024 | Clarus |
| New World Medical,INC. | $18.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.